811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1-Reference-Cited by-同舟云学术

811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

Published:2020-09 Issue: Volume:31 Page:S613
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Banerjee S.,Moore K.N.,Colombo N.,Scambia G.,Kim B-G.,Oaknin A.,Friedlander M.,Lisyanskaya A.,Floquet A.,Leary A.,Sonke G.S.,Gourley C.,Oza A.,Martín A. González,Aghajanian C.,Bradley W.,Holmes E.,Lowe E.S.,DiSilvestro P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI];Current Women s Health Reviews;2024-02

2. Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives;Current Opinion in Obstetrics & Gynecology;2023-12-04

3. Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer;International Journal of Gynecologic Cancer;2023-11-24

4. Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey;Cancers;2023-11-15

5. The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next‐generation sequencing;Genes, Chromosomes and Cancer;2023-05-24